Cargando…
Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233960/ https://www.ncbi.nlm.nih.gov/pubmed/34242571 http://dx.doi.org/10.1016/j.ccell.2021.06.015 |
| _version_ | 1783713971614777344 |
|---|---|
| author | Hill, Joshua A. Ujjani, Chaitra S. Greninger, Alexander L. Shadman, Mazyar Gopal, Ajay K. |
| author_facet | Hill, Joshua A. Ujjani, Chaitra S. Greninger, Alexander L. Shadman, Mazyar Gopal, Ajay K. |
| author_sort | Hill, Joshua A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8233960 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82339602021-06-28 Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient Hill, Joshua A. Ujjani, Chaitra S. Greninger, Alexander L. Shadman, Mazyar Gopal, Ajay K. Cancer Cell Letter Elsevier Inc. 2021-08-09 2021-06-26 /pmc/articles/PMC8233960/ /pubmed/34242571 http://dx.doi.org/10.1016/j.ccell.2021.06.015 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Hill, Joshua A. Ujjani, Chaitra S. Greninger, Alexander L. Shadman, Mazyar Gopal, Ajay K. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title | Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title_full | Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title_fullStr | Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title_full_unstemmed | Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title_short | Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient |
| title_sort | immunogenicity of a heterologous covid-19 vaccine after failed vaccination in a lymphoma patient |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233960/ https://www.ncbi.nlm.nih.gov/pubmed/34242571 http://dx.doi.org/10.1016/j.ccell.2021.06.015 |
| work_keys_str_mv | AT hilljoshuaa immunogenicityofaheterologouscovid19vaccineafterfailedvaccinationinalymphomapatient AT ujjanichaitras immunogenicityofaheterologouscovid19vaccineafterfailedvaccinationinalymphomapatient AT greningeralexanderl immunogenicityofaheterologouscovid19vaccineafterfailedvaccinationinalymphomapatient AT shadmanmazyar immunogenicityofaheterologouscovid19vaccineafterfailedvaccinationinalymphomapatient AT gopalajayk immunogenicityofaheterologouscovid19vaccineafterfailedvaccinationinalymphomapatient |